Cinclus Pharma
M├╢lndal
About Cinclus Pharma
Cinclus Pharma is a research based biotech company developing small molecules for the treatment of gastric acid related diseases. Their main asset, X842, has been studied in a Phase I clinical trial. Cinclus Pharma is based in Basel, Switzerland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $59.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Mar 2026)
- Ticker: sto:CINPHA
- Website: cincluspharma.com
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cinclus-pharma-70635 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.